Is there a role for 5-HT1A agonists in the treatment of depression?
- 1 February 2003
- journal article
- review article
- Published by Elsevier BV in Biological Psychiatry
- Vol. 53 (3), 193-203
- https://doi.org/10.1016/s0006-3223(02)01643-8
Abstract
No abstract availableKeywords
This publication has 74 references indexed in Scilit:
- Mirtazapine compared with paroxetine in major depression.The Journal of Clinical Psychiatry, 2000
- The use of pindolol with fluoxetine in the treatment of major depression: final results from a double-blind, placebo-controlled trialBiological Psychiatry, 1999
- Selective Activation of Postsynaptic 5-HT1A Receptors Induces Rapid Antidepressant ResponseNeuropsychopharmacology, 1997
- Current advances and trends in the treatment of depressionTrends in Pharmacological Sciences, 1994
- Gepirone, a selective serotonin (5HT1A) partial agonist in the treatment of major depressionProgress in Neuro-Psychopharmacology and Biological Psychiatry, 1992
- Tandospirone and its metabolite, 1-(2-pyrimidinyl)-piperazine—II. Effects of acute administration of 1-PP and long-term adminstration of tandospirone on noradrenergic neurotransmissionNeuropharmacology, 1991
- Differential Effect of Gepirone on Presynaptic and Postsynaptic Serotonin ReceptorsJournal of Clinical Psychopharmacology, 1990
- Novel anxiolytics discriminate between postsynaptic serotonin receptors mediating different physiological responses on single neurons of the rat hippocampusNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1987
- Modification of 5‐HT neuron properties by sustained administration of the 5‐HT1A agonist gepirone: Electrophysiological studies in the rat brainSynapse, 1987
- Hyperpolarization of serotonergic neurons by serotonin and LSD: Studies in brain slices showing increased K+ conductanceBrain Research, 1984